Clinical trial
A Randomized, Multicenter, Double-Blind, Parallel, Placebo-controlled Phase 2b Clinical Trial to Evaluate the Efficacy and Safety of YN001 in Adults With Coronary Atherosclerosis
NCT07521007 is registered in ClinicalTrials.gov with Beijing Inno Medicine Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Multicenter, Double-Blind, Parallel, Placebo-controlled Phase 2b Clinical Trial to Evaluate the Efficacy and Safety of YN001 in Adults With Coronary Atherosclerosis
- Lead sponsor
- Beijing Inno Medicine Co., Ltd.
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- July 31, 2026
- Completion date
- March 31, 2029
- Enrollment
- 456 (estimated)
- Sites
- 56
Conditions
As the registry lists them; a condition with its own page is linked.